Dernières nouvelles pour Cannara Biotech (OTC:LOVFF) Stock

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

CANNARA BIOTECH INC by Cannara Biotech Inc.

Cannara Biotech Inc

CIBC analyst Cosmos Chiu maintains Franco-Nevada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FNV#TSX">FNV</a>) with a Outperformer and raises the price target from C$290 to C$315.

News

Price Target

Analyst Ratings

TSX:FNV

CIBC Maintains Outperformer on Franco-Nevada, Raises Price Target to C$315

<a href="https://asia.nikkei.com/Business/Pharmaceuticals/Japan-discards-2.5m-doses-of-expired-COVID-drugs-from-Pfizer-Merck">https://asia.nikkei.com/Business/Pharmaceuticals/Japan-discards-2.5m-doses-of-expired-COVID-drugs-from-Pfizer-Merck</a>

General

'Japan discards 2.5m doses of expired COVID drugs from Pfizer, Merck'- Nikkei Asia

Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock saw a significant gain on Tuesday, mirroring a broader positive trend in the semiconductor sector. This surge was primarily driven by two key developments: reports indicating the Trump administration&#8217;s plans for<a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46412125/trumps-latest-move-on-ai-and-china-propels-chip-stocks" rel="noreferrer noopener"> substantial AI and energy investments</a> in Pennsylvania, and the U.S. government&#8217;s decision to ease certain chip export restrictions to China.
President Donald Trump is set to announce a $70 billion initiative near Pittsburgh on Tuesday. This comprehensive plan focuses on investments in AI data centers, expanded power generation, grid upgrades, and new training programs, all aimed at bolstering U.S. leadership in AI.
The initiative seeks to achieve this by encouraging private investment, streamlining regulations, and accelerating project permits. Complementing this, Blackstone President Jon Gray is also expected to unveil a $25 billion push specifically for data center and energy infrastructure.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46326271/nvidia-breaks-4-trillion-barrier-benzinga-poll-predicted-it-first">Nvidia Breaks $4 Trillion Barrier—Benzinga Poll Predicted It First</a>
Simultaneously, chip stocks, including Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), experienced a boost after the U.S. government relaxed export restrictions on certain chips to China.
Supermicro&#8217;s stock is currently trading above its 50-day moving average of $42.58. The company itself is <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46314112/super-micro-accelerates-european-footprint-to-meet-exploding-ai-needs" rel="noreferrer noopener">actively expanding </a>to meet the surging demand for AI infrastructure. It plans to increase investment in Europe, exploring new sites beyond its existing Netherlands facility.
Domestically, Supermicro is scaling up server production in Mississippi and Texas, a move designed to support U.S.-based AI data center growth, which is being fueled by major tech firms and the Trump administration&#8217;s emphasis on domestic manufacturing.
Year-to-date, Supermicro stock has surged over 75%, significantly outperforming the S&amp;P 500 Index&#8217;s over 6% gain. However, a cautious note was struck on July 9 by Bank of America Securities analyst Ruplu Bhattacharya.
He warned that <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/07/46325914/super-micro-remains-a-show-me-story-as-analysts-weigh-ai-growth-against-execution-risks" rel="noreferrer noopener">intensifying competition</a> in the AI server market could put pressure on margins, and limited access to critical components like GPUs and liquid cooling might cap revenue growth.
Bhattacharya suggested that rivals such as Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and Hewlett-Packard Enterprise Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) possess an advantage in the enterprise sector. He further predicted that liquid cooling could eventually become commoditized, potentially eroding Supermicro&#8217;s current competitive edge.
While acknowledging the company&#8217;s strong AI-driven growth, the analyst characterized it as a &#8220;show-me story&#8221; due to concerns about stock volatility, litigation risks, and execution challenges.
Despite its recent gains, the stock remains down over 39% in the last 12 months. This decline is largely attributable to <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46314112/super-micro-accelerates-european-footprint-to-meet-exploding-ai-needs" rel="noreferrer noopener">increased regulatory scrutiny</a> of Supermicro&#8217;s internal financing controls following the resignation of its independent auditor last October, which caused delays in financial filings.
Additionally, ongoing tariff uncertainties forced the company to postpone orders and subsequently lower its fiscal year revenue forecast to between $21.8 billion and $22.6 billion, down from the previous range of $23.5 billion to $25 billion.
Price Action: SMCI shares were trading higher by 7.23% to $53.31 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/07/46423783/why-metas-ai-edge-makes-it-the-top-ad-stock-for-2025" target="_blank" rel="noreferrer noopener">Why Meta&#8217;s AI Edge Makes It The Top Ad Stock For 2025</a></li>
</ul>
Photo by Shutterstock

Movers

Tech

DELL

NVDA

SMCI

Supermicro Stock Surges On Trump's AI Push, Eased China Chip Curbs

Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) shares are trading slightly<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> higher on Tuesday.</a>
What Happened: The firm is taking a step in democratizing IP licensing for game creators with the rollout of its new licensing platform, which includes the Roblox License <a href="https://www.benzinga.com/pressreleases/25/07/b46422860/roblox-announces-new-licensing-platform-for-experiences" target="_blank" rel="noreferrer noopener">Manager and Licenses catalog.</a>
The move is expected to transform how intellectual property is managed and used within the Roblox ecosystem, the company said in a press release.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/07/46283392/what-fueled-robloxs-85-surge-in-2025" rel="noreferrer noopener">What Fueled Roblox&#8217;s 85% Surge In 2025?</a>
According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, Roblox stock has gained over 173% in the past year. Investors can gain exposure to the stock via Bitwise Web3 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWEB#NYSE">BWEB</a>).
The new tools allow rights holders to offer licenses directly to Roblox creators, enabling scalable, self-service integration of well-known IP into games and interactive experiences.
Historically, game licensing has been dominated by large studios due to the complexity and resources involved.
Roblox&#8217;s new License Manager streamlines this process by allowing IP owners to set customized license terms, scan for IP usage across games, and offer rights to creators more efficiently, potentially in a matter of hours instead of months.
The Licenses catalog functions as a marketplace, where creators can explore available IPs and request usage rights.
This new infrastructure is aimed at bringing more recognizable content to the platform while expanding opportunities for smaller developers and fan creators.
Roblox Launches Platform With Notable Partners: Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is opening up franchise titles such as Stranger Things and Squid Game for use, while Lions Gate Entertainment Corp. is contributing IP from its franchises, such as Twilight and Saw.
&#8220;We&#8217;re excited to engage with the Roblox creator community and can&#8217;t wait to see the innovative experiences they bring to life with our IP,&#8221; said Jenefer Brown, executive vice president at Lionsgate.
Roblox&#8217;s Chief Product Officer Manuel Bronstein stated that the company aims for 10% of all gaming content revenue to flow through its ecosystem. This initiative marks the beginning of a larger plan to bring more IP holders onto the platform and provide creators with diverse, flexible licensing options.
More license types and open access to License Manager are anticipated in the near future.
RBLX Price Action: Roblox shares are trading higher by 0.61% to $112.52 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46425563/tesla-rival-rivians-custom-google-maps-is-here" target="_blank" rel="noreferrer noopener">Tesla Rival Rivian&#8217;s Custom Google Maps Is Here</a></li>
</ul>
Photo: Shutterstock

Entertainment

Equities

Gaming

Markets

Media

BWEB

NFLX

RBLX

What's Going On With Roblox Stock On Tuesday?

<a href="https://truthsocial.com/@realDonaldTrump/114858589029028619">https://truthsocial.com/@realDonaldTrump/114858589029028619</a>

Macro Notification

Politics

iShares MSCI Indonesia Investable Market Index Fund

EIDO

President Trump Says Ranchers, Farmers, And Fishermen Will Have Complete And Total Access To The Indonesian Market; U.S. Exports To Indonesia Are To Be Tariff And Non-Tariff Barrier Free

Economics

President Trump Says Tuesday Morning I Finalized An Important Deal With Republic Of Indonesia After Speaking With Their Highly Respected President Prabowo Subianto; Indonesia Has Committed To Purchasing $15B Dollars In U.S. Energy; $4.5B Dollars In American Agricultural Products, And 50 Boeing Jets

Reuters Reports Senate Commerce Chair Ted Cruz To Propose Legislation To Require Use Of Advanced Aircraft-tracking Technology By U.S. Army Helicopters

CIBC analyst Anita Soni maintains Equinox Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#TSX">EQX</a>) with a Neutral and raises the price target from C$10 to C$11.

TSX:EQX

CIBC Maintains Neutral on Equinox Gold, Raises Price Target to C$11

Kairos Pharma, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#NYSE">KAPA</a>) stock is trading higher on Tuesday, with a strong session volume of 221 million compared to the average volume of 874.3K <a href="https://www.benzinga.com/pro/feature/newsfeed" target="_blank" rel="noreferrer noopener">as per data from Benzinga Pro</a>.
The company on Tuesday released safety results from its ongoing Phase 2 clinical trial of ENV-105 (carotuximab) in patients with metastatic castration-<a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">resistant prostate cancer (mCRPC)</a>.
The interim safety analysis of the trial demonstrated that ENV-105, a first-in-class CD105 antagonist, was well tolerated when combined with standard of care hormone therapy, apalutamide, from the <a href="https://www.benzinga.com/pressreleases/25/07/b46412468/kairos-pharma-announces-positive-safety-results-from-phase-2-trial-of-env-105-in-advanced-prostate" target="_blank" rel="noreferrer noopener">first 10 enrolled patients</a>.
Thus far, no dose-limiting toxicities or unexpected adverse events have been reported.
In addition, the treatment-related side effects were manageable with standard supportive care. Notably, no Grade 3 or 4 toxicities were observed.
The randomized Phase 2 trial aims to enroll 100 patients.
The study is designed to evaluate the safety, tolerability and early signs of efficacy of ENV-105, a CD105 antagonist, in men whose disease has progressed following standard hormone-based therapies.
Interim efficacy data from the trial are expected to be reported in September 2025.
Kairos Pharma plans to engage with regulatory agencies to discuss the design of a potential pivotal Phase 3 study, based on emerging data.
<h1 class="wp-block-heading">How To Buy KAPA Stock</h1>
By now, you're likely curious about how to participate in the market for Kairos Pharma — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Kairos Pharma, which is trading at $1.12 at time of writing the article, $100 would buy you 89.29 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading; either way, it allows you to profit from the share price decline.
KAPA Price Action: Kairos stock is up 57.64% at $1.08 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/07/46422344/how-chewys-smart-moves-could-capture-over-1-billion-in-revenue" target="_blank" rel="noreferrer noopener">How Chewy&#8217;s Smart Moves Could Capture Over $1 Billion In Revenue</a></li>
</ul>
Photo: Who is Danny via Shutterstock

Biotech

Health Care

Trading Ideas

KAPA

Why Is Kairos Pharma Stock Surging On Tuesday?

<a href="https://www.freep.com/story/money/cars/general-motors/2025/07/15/gm-escalade-silverado-sierra-orion-assembly/84164837007/">https://www.freep.com/story/money/cars/general-motors/2025/07/15/gm-escalade-silverado-sierra-orion-assembly/84164837007/</a>

'GM's Orion Assembly to build Cadillac Escalade, Chevrolet Silverado, GMC Sierra in 2027'- Detroit Free Press

WIIM

Shares of homebuilders are trading lower. Housing-related stocks may be down amid a recent rise in mortgage rates.

Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) shares traded higher on Tuesday after the cloud communications company announced several new platform capabilities aimed at enhancing real-time, personalized customer <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/b46414341/twilio-expands-platform-capabilities-with-general-availability-of-real-time-personalization-data-r" rel="noreferrer noopener">experiences across channels.</a>
The company introduced general availability for three key tools: Event-Triggered Journeys in Twilio Engage, Data Residency for Email (EU), and WhatsApp Business Calling via Programmable Voice.
These innovations aim to unify data, communications, and AI in one platform to help businesses better meet compliance needs while delivering more relevant and timely customer interactions.
Also Read:<a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/b46414341/twilio-expands-platform-capabilities-with-general-availability-of-real-time-personalization-data-r" rel="noreferrer noopener"> Twilio&#8217;s AI Push, Microsoft Partnership Spark Analyst Optimism</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TWLO stock has gained over 119% in the past year. Investors can gain exposure to the stock via&nbsp;Global X Cloud Computing ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOU#NASDAQ">CLOU</a>).
Twilio Segment&#8217;s Event-Triggered Journeys provide businesses with the ability to automate customer experiences based on real-time behavior. This feature supports scenarios like cart abandonment, onboarding flows, trial-to-paid transitions, and more.
Using rich data payloads, businesses can personalize messages with context such as loyalty status or account info while managing multiple interactions simultaneously across devices.
Companies can now dynamically build journeys without developer intervention, track real-time user behavior, and gain full visibility into campaign effectiveness.
Native integrations with SendGrid and Twilio Messaging further streamline cross-channel communication, enabling email and SMS triggers directly from customer data.
Twilio also rolled out Data Residency for Email (EU), helping clients store email event data and personally identifiable information (PII) within Europe.
This functionality is designed to support end-to-end regional data control and streamline compliance with evolving privacy standards. Companies stand to benefit from improved delivery times and reduced risk of cross-border data exposure.
Through Programmable Voice, businesses can now engage with customers via voice calls directly within WhatsApp conversations.
This feature supports seamless transitions between text and voice, offering fluid communication for service use cases. The API-based deployment simplifies rollout across global messaging environments.
&#8220;With Data Residency for Email (EU), WhatsApp Business Calling, and our next-generation orchestration capabilities in Twilio Segment, we&#8217;re helping businesses respond to customer behavior and earn their trust in real time, scale globally, and enjoy a simplified, more productive builder experience,&#8221; said Inbal Shani, Chief Product Officer at Twilio.
Price Action: TWLO shares are trading higher by 7.73% to $127.50&nbsp;at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46421525/whats-going-on-with-lucid-group-stock-on-tuesday-3" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Lucid Group Stock On Tuesday?</a></li>
</ul>
Photo by Tada Images via Shutterstock

CLOU

TWLO

Why Is Twilio Stock Soaring On Tuesday?

CIBC analyst Cosmos Chiu maintains Endeavour Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>) with a Neutral and raises the price target from C$7.25 to C$10.

CIBC Maintains Neutral on Endeavour Silver, Raises Price Target to C$10

Mizuho analyst John Baumgartner maintains Simply Good Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) with a Outperform and lowers the price target from $47 to $43.

SMPL

Mizuho Maintains Outperform on Simply Good Foods, Lowers Price Target to $43

Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $13.5, a high estimate of $14.00, and a low estimate of $12.50. This upward trend is apparent, with the current average reflecting a 3.85% increase from the previous average price target of $13.00.
<img src="https://www.benzinga.com/files/images/story/2025/1752602496_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Rithm Capital among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Douglas Harter</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Kenneth Lee</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Jay McCanless</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>Jones Trading</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.50</td>
<td>$12.50</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$12.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Rithm Capital. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Rithm Capital compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Rithm Capital's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RITM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rithm Capital analyst ratings.</a>
<h2>Get to Know Rithm Capital Better</h2>
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
<h3>Rithm Capital: Financial Performance Dissected</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Rithm Capital's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -36.9%. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 7.41%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Rithm Capital's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.56%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Rithm Capital's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.08%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Rithm Capital's debt-to-equity ratio surpasses industry norms, standing at 4.94. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RITM

Assessing Rithm Capital: Insights From 5 Financial Analysts

5 analysts have expressed a variety of opinions on Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $180.2, a high estimate of $196.00, and a low estimate of $172.00. Surpassing the previous average price target of $175.40, the current average has increased by 2.74%.
<img src="https://www.benzinga.com/files/images/story/2025/1752602487_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Sprouts Farmers Market. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$173.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Mike Dahl</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$172.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Michael Morris</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$185.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Mark Carden</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$196.00</td>
<td>$195.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Sprouts Farmers Market. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Sprouts Farmers Market compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Sprouts Farmers Market's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Sprouts Farmers Market's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SFM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Sprouts Farmers Market analyst ratings.</a>
<h2>Get to Know Sprouts Farmers Market Better</h2>
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
<h3>Understanding the Numbers: Sprouts Farmers Market's Finances</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Positive Revenue Trend: Examining Sprouts Farmers Market's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 18.72% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Sprouts Farmers Market's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 8.05%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Sprouts Farmers Market's ROE excels beyond industry benchmarks, reaching 13.8%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Sprouts Farmers Market's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.88% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Sprouts Farmers Market's debt-to-equity ratio is below the industry average at 1.33, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Sprouts Farmers Market: 5 Analysts Share Their Views

Ratings for Virtu Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NYSE">VIRT</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $39.29, a high estimate of $48.00, and a low estimate of $28.00. This current average reflects an increase of 5.79% from the previous average price target of $37.14. 
<img src="https://www.benzinga.com/files/images/story/2025/1752602479_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Virtu Finl is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Alex Kramm</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$28.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Kaimon Chung</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$42.00</td>
<td>$41.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Virtu Finl. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Virtu Finl compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Virtu Finl's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Virtu Finl's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/VIRT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Virtu Finl analyst ratings.</a>
<h2>All You Need to Know About Virtu Finl</h2>
Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
<h3>Financial Milestones: Virtu Finl's Journey</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Virtu Finl's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 30.34% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 11.14%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Virtu Finl's ROE stands out, surpassing industry averages. With an impressive ROE of 7.28%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Virtu Finl's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.57%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 5.99, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VIRT

Forecasting The Future: 7 Analyst Projections For Virtu Finl

Vital Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTLE#NYSE">VTLE</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $20.0, a high estimate of $23.00, and a low estimate of $15.00. Observing a downward trend, the current average is 12.4% lower than the prior average price target of $22.83. 
<img src="https://www.benzinga.com/files/images/story/2025/1752602454_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Vital Energy's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Vital Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Vital Energy compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Vital Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Vital Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VTLE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Vital Energy analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Vital Energy</h2>
Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.
<h3>Breaking Down Vital Energy's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3M period, Vital Energy showcased positive performance, achieving a revenue growth rate of 6.19% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: Vital Energy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -3.68%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -0.7%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Vital Energy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.33%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Vital Energy's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.9, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VTLE

Analyst Expectations For Vital Energy's Future

Allstate's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) short percent of float has risen 12.71% since its last report. The company recently reported that it has 4.72 million shares sold short, which is 2.04% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Allstate Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752602443_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Allstate has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Allstate's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Allstate's peer group average for short interest as a percentage of float is 2.87%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Do Investors Really Feel About Allstate?

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFX#NYSE">TFX</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $144.4, along with a high estimate of $173.00 and a low estimate of $130.00. This current average has decreased by 6.48% from the previous average price target of $154.40. 
<img src="https://www.benzinga.com/files/images/story/2025/1752602440_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Teleflex. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$130.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$137.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Patrick Wood</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$173.00</td>
<td>$191.00</td>
</tr>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$145.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Larry Biegelsen</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$137.00</td>
<td>$146.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Teleflex. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Teleflex compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Teleflex's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Teleflex's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TFX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Teleflex analyst ratings.</a>
<h2>Delving into Teleflex's Background</h2>
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
<h3>A Deep Dive into Teleflex's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Teleflex faced challenges, resulting in a decline of approximately -5.04% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Teleflex's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 13.56% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.27%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Teleflex's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.33% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Teleflex's debt-to-equity ratio is below the industry average at 0.49, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Press Releases

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

Earnings

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy

Comments

Cannara Biotech

Actualités

Dernières nouvelles pour Cannara Biotech (OTC:LOVFF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL